Bacteriophage therapy as a treatment option for complex cardiovascular implant infection: The German Heart Center Berlin experience
METADATA ONLY
Loading...
Author / Producer
Date
2022-05
Publication Type
Journal Article
ETH Bibliography
yes
Citations
Altmetric
METADATA ONLY
Data
Rights / License
Abstract
Conventional antimicrobials have low or no activity against multidrug-resistant or chronic implant-associated infections. Lytic bacteriophages can rapidly and selectively kill bacteria, and can be combined with antibiotics. However, clinical experience of bacteriophage therapy in patients with cardiovascular infections is limited. We documented the outcome and safety of intravenous and local adjunctive bacteriophage therapy, to treat chronic relapsing cardiovascular implant infections at our institution.
Permanent link
Publication status
published
External links
Editor
Book title
Journal / series
Volume
41 (5)
Pages / Article No.
551 - 555
Publisher
Elsevier
Event
Edition / version
Methods
Software
Geographic location
Date collected
Date created
Subject
cardiovascular implant infections; multidrug resistant infections; biofilm infections; bacteriophage therapy; alternative therapy
Organisational unit
09667 - Falk, Volkmar (ehemalig) / Falk, Volkmar (former)